Joy Cavagnaro
President at Access BIO
Joy Cavagnaro is the President of Access BIO where she consults on science-based development strategies for novel drug, biologics and device combinations. Her career spans academia, the CRO and biotechnology industries and government. During her tenure at CBER/FDA she was appointed to the SBRS and served as FDA’s safety topic lead and rapporteur for “ICH S6.” She was the first to advocate the “case-by-case” rational science-based approach to preclinical safety evaluation. Dr. Cavagnaro is Past Chair of RAPS and the National Capital Area Chapter of SOT. In 2011 she received SOT’s Biotechnology Specialty Section First Career Achievement Award and in 2019 the Arnold J. Lehman Award. She is Founder, Past Chair and Chair of the leadership committee of BioSafe, an expert preclinical science committee within BIO. She is a Past Chair of the Clinical and Regulatory Affairs Committee and Translational Science & Product Development Committee of the ASGCT. She was a member of the Scientific Advisory Committee on Alternative Toxicological Methods and is currently an advisor and member of the Grants Working Group of the California Institute of Regenerative Medicine.
Visit website: https://www.sarepta.com/about-us/leadership/joy-cavagnaro-phd-dabt-fellow-ats
Details last updated 17-Jul-2025
Joy Cavagnaro is also referenced in the following:
Regulatory Primer for LongBio Companies
18-Jul-2025
Webinar organised by The Kitalys Institute Targeting Healthy Longevity 2025 (FREE)